Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease
Read time: 1 mins
Last updated:30th Apr 2013
The primary purpose of this study is to assess the safety and optimal delivery of the Neo-Kidney Augment (NKA) when implanted at one site in a recipient kidney. NKA is made from expanded autologous, homologous, selected renal cells (SRC) obtained from the patient's kidney biopsy.
|Study start date||2013-04-30|